{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:50Z","timestamp":1792807190305,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["Puducherry-6"],"award-info":[{"award-number":["Puducherry-6"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.seizure.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T18:07:41Z","timestamp":1528222061000},"page":"57-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid"],"prefix":"10.1016","volume":"60","author":[{"given":"Yadav","family":"Nisha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah","family":"Bobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Wadwekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seizure.2018.06.003_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"8","key":"10.1016\/j.seizure.2018.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4236\/abb.2012.38136","article-title":"Oxidative stress and its complications in human health","volume":"3","author":"Koksal","year":"2012","journal-title":"Adv Biosci Biotechnol"},{"issue":"January (1)","key":"10.1016\/j.seizure.2018.06.003_bib0015","first-page":"153","article-title":"Effects of treatment with antiepileptic drugs on serum lipid profile in epileptic children","volume":"12","author":"Kantoush","year":"1998","journal-title":"Alex J Pediatr"},{"issue":"3","key":"10.1016\/j.seizure.2018.06.003_bib0020","first-page":"125","article-title":"Valproate-induced insulin resistance and obesity in children","volume":"71","author":"Verrotti","year":"2009","journal-title":"Horm Res"},{"issue":"February (2)","key":"10.1016\/j.seizure.2018.06.003_bib0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl._(1)","key":"10.1016\/j.seizure.2018.06.003_bib0030","doi-asserted-by":"crossref","first-page":"s64","DOI":"10.1210\/jc.2008-1613","article-title":"Adipocytokines and the metabolic complications of obesity","volume":"93","author":"Rasouli","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.seizure.2018.06.003_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","article-title":"Adiponectin: action, regulation and association to insulin sensitivity","volume":"6","author":"Lihn","year":"2005","journal-title":"Obes Rev"},{"issue":"11","key":"10.1016\/j.seizure.2018.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.wnl.0000187074.27586.d1","article-title":"Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid","volume":"65","author":"Greco","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2018.06.003_bib0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"issue":"January (1)","key":"10.1016\/j.seizure.2018.06.003_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.seizure.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/795259","article-title":"Oxidative Stress and Epilepsy: Literature Review","volume":"2012","author":"Aguiar","year":"2012","journal-title":"Oxid Med Cell Longev."},{"issue":"6","key":"10.1016\/j.seizure.2018.06.003_bib0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/1570159X12666140923205715","article-title":"Antioxidants as a preventive treatment for epileptic process: a review of the current status","volume":"12","author":"Martinc","year":"2014","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2018.06.003_bib0065","first-page":"590","article-title":"The lipid peroxidation product as a marker of oxidative stress in epilepsy","volume":"6","author":"Pandey","year":"2012","journal-title":"J Clin Diagn Res."},{"issue":"January (1)","key":"10.1016\/j.seizure.2018.06.003_bib0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis: antiepileptic drugs and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.06.003_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a New colorimetric method","volume":"90","author":"Satoh","year":"1978","journal-title":"Clin Chim Acta."},{"issue":"July (1)","key":"10.1016\/j.seizure.2018.06.003_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal Biochem."},{"issue":"May (3)","key":"10.1016\/j.seizure.2018.06.003_bib0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsy Behav."},{"issue":"October (8)","key":"10.1016\/j.seizure.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.seizure.2012.06.001","article-title":"Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate","volume":"21","author":"Fang","year":"2012","journal-title":"Seizure."},{"issue":"September (4)","key":"10.1016\/j.seizure.2018.06.003_bib0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(01)00806-3","article-title":"Altered ovarian function and cardiovascular risk factors in valproate-treated women","volume":"111","author":"Isoj\u00e4rvi","year":"2001","journal-title":"Am J Med."},{"issue":"October (4)","key":"10.1016\/j.seizure.2018.06.003_bib0100","first-page":"22","article-title":"Effects of topiramate vs valproate on serum leptin and lipid peroxidation in epileptic patients","volume":"2","author":"Thanoon","year":"2013","journal-title":"IJAPBS"},{"issue":"4","key":"10.1016\/j.seizure.2018.06.003_bib0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1254\/jphs.FPJ04032X","article-title":"Blood levels of trace elements, electrolytes, and oxidative stress\/antioxidant systems in epileptic patients","volume":"96","author":"Hamed","year":"2004","journal-title":"J Pharmacol Sci."},{"issue":"July (5)","key":"10.1016\/j.seizure.2018.06.003_bib0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10571-013-9936-5","article-title":"Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements","volume":"33","author":"Naz\u0131ro\u011flu","year":"2013","journal-title":"Cell Mol Neurobiol"},{"issue":"September (9)","key":"10.1016\/j.seizure.2018.06.003_bib0115","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1528-1167.2006.00546.x","article-title":"Characterization of insulin secretion in valproate-treated patients with epilepsy","volume":"47","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsia"},{"issue":"September (5)","key":"10.1016\/j.seizure.2018.06.003_bib0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.freeradbiomed.2010.12.005","article-title":"Oxidative stress and the etiology of insulin resistance and type 2 diabetes","volume":"51","author":"Henriksen","year":"2011","journal-title":"Free Radic Biol Med."},{"issue":"January (1)","key":"10.1016\/j.seizure.2018.06.003_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000113927","article-title":"Valproic acid and CEBP \u03b1 -mediated regulation of adipokine Gene expression in hypothalamic neurons and 3T3-L1 adipocytes","volume":"88","author":"Brown","year":"2008","journal-title":"Neuroendocrinology."},{"issue":"May (5)","key":"10.1016\/j.seizure.2018.06.003_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia."},{"issue":"May","key":"10.1016\/j.seizure.2018.06.003_bib0135","first-page":"629","article-title":"Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south indians","volume":"131","author":"Sandeep","year":"2010","journal-title":"Indian J Med Res."},{"issue":"March (3)","key":"10.1016\/j.seizure.2018.06.003_bib0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0971-5916.182623","article-title":"Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs","volume":"143","author":"Sarangi","year":"2016","journal-title":"Indian J Med Res."}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111830089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111830089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:51:06Z","timestamp":1761011466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111830089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S105913111830089X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.06.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}